169
Views
17
CrossRef citations to date
0
Altmetric
Original Research

EDTA-modified mesoporous silica as supra adsorbent of copper ions with novel approach as an antidote agent in copper toxicity

, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 7781-7792 | Published online: 26 Sep 2019

References

  • Whitesides GM. Nanoscience, nanotechnology, and chemistry. Small. 2005;1:172–179. doi:10.1002/smll.20040013017193427
  • Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2012;64:24–36. doi:10.1016/j.addr.2012.09.006
  • Farjadian F, Moghoofei M, Mirkiani S, et al. Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: set the bugs to work? Biotechnol Adv. 2018;36(4):968–985. doi:10.1016/j.biotechadv.2018.02.01629499341
  • Park K. Controlled drug delivery systems: past forward and future back. J Controlled Release. 2014;190:3–8. doi:10.1016/j.jconrel.2014.03.054
  • Edgar JYC, Wang H. Introduction for design of nanoparticle based drug delivery systems. Curr Pharm Des. 2017;23(14):2108–2112. doi:10.2174/138161282266616102515400327784242
  • Lamichhane N, Udayakumar T, D’Souza W, et al. Liposomes: clinical applications and potential for image-guided drug delivery. Molecules. 2018;23(2):288. doi:10.3390/molecules23020288
  • Hosseini M, Farjadian F, Makhlouf ASH. Smart stimuli-responsive nano-sized hosts for drug delivery. Industrial Applications Intelligent Polym Coat. 2016;1–26. doi.org/10.1007/978-3-319-26893-4_1
  • Noriega-Luna B, Godínez LA, Rodríguez FJ, et al. Applications of dendrimers in drug delivery agents, diagnosis, therapy, and detection. J Nanomater. 2014;2014:39. doi:10.1155/2014/507273
  • Dadfar SM, Roemhild K, Drude NI, et al. Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019;138:302–325. doi:10.1016/j.addr.2019.01.00530639256
  • Hornos Carneiro MF, Barbosa JF. Gold nanoparticles: a critical review of therapeutic applications and toxicological aspects. J Toxicol Environ Health Part B. 2016;19(3–4):129–148. doi:10.1080/10937404.2016.1168762
  • Medintz IL, Mattoussi H, Clapp AR. Potential clinical applications of quantum dots. Int J Nanomedicine. 2008;3(2):151.18686776
  • Ahmed W, Elhissi A, Dhanak V, Subramani K. Chapter 18—carbon nanotubes: applications in cancer therapy and drug delivery research. Emerging Nanotechnol Dent. 2nd ed.; Subramani, K., Ahmed, W., Eds 371–389. doi:10.1016/B978-0-12-812291-4.00018-2
  • Baeza A, Ruiz-Molina D, Vallet-Regí M. Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks. Expert Opin Drug Deliv. 2017;14(6):783–796. doi:10.1080/17425247.2016.122929827575454
  • Eurov DA, Kurdyukov DA, Stovpiaga EY, et al. Hypersonic properties of monodisperse spherical mesoporous silica particles. J Phys D Applied Phys. 2014;47(33):5. doi:10.1088/0022-3727/47/33/335303
  • Farjadian F, Roointan A, Mohammadi-Samani S, Hosseini M. Mesoporous silica nanoparticles: synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. Chem Eng J. 2019;359:684–705. doi:10.1016/j.cej.2018.11.156
  • BernArdos A, KouřimsKá L. Applications of mesoporous silica materials in food-a review. Czech J Food Sci. 2013;31(2):99–107. doi:10.17221/240/2012-CJFS
  • He Q, Zhang Z, Gao F, Li Y, Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small. 2011;7(2):271–280. doi:10.1002/smll.20100145921213393
  • Yang P, Gaib S, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev. 2012;41(9):3679–3698. doi:10.1039/c2cs15308d22441299
  • ALOthman ZA. A review: fundamental aspects of silicate mesoporous materials. Materials (Basel). 2012;5(12):2874–2902. doi:10.3390/ma5122874
  • Mehmood A, Ghafar H, Yaqoob S, Gohar U, Ahmad B. Mesoporous silica nanoparticles: a review. J Dev Drugs. 2017;6(2):1000174. doi:10.4172/2329-6631.1000174.
  • Narayan R, Nayak U, Raichur A, Garg S. Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics. 2018;10(3):118. doi:10.3390/pharmaceutics10030118
  • Farjadian F, Hosseini M, Ghasemi S, Tamami B. Phosphinite-functionalized silica and hexagonal mesoporous silica containing palladium nanoparticles in Heck coupling reaction: synthesis, characterization, and catalytic activity. RSC Adv. 2015;5(97):79976–79987. doi:10.1039/C5RA16131B
  • Duhan S, Tomer VK. Mesoporous silica: making “sense” of sensors. Adv Sensor Detect Mater. 2014;6:149–192. doi:10.1002/9781118774038.ch6
  • Karimi M, Mirshekari H, Aliakbari M, Sahandi-Zangabad P, Hamblin MR. Smart mesoporous silica nanoparticles for controlled-release drug delivery. Nanotechnol Rev. 2016;5(2):195–207. doi:10.1515/ntrev-2015-0057
  • Cha BG, Kim J. Functional mesoporous silica nanoparticles for bio‐imaging applications. Wiley Interdiscip Rev. 2019;11(1):e1515.
  • Abdelsamad AM, Khalil AS, Ulbricht M. Influence of controlled functionalization of mesoporous silica nanoparticles as tailored fillers for thin-film nanocomposite membranes on desalination performance. J Memb Sci. 2018;563:149–161. doi:10.1016/j.memsci.2018.05.043
  • Farjadian F, Azadi S, Mohammadi-Samani S, Ashrafi H, Azadi A. A novel approach to the application of hexagonal mesoporous silica in solid-phase extraction of drugs. Heliyon. 2018;4(11):e00930. doi:10.1016/j.heliyon.2018.e0093030456326
  • Cashin VB, Eldridge DS, Yu A, Zhao D. Surface functionalization and manipulation of mesoporous silica adsorbents for improved removal of pollutants: a review. Environ Sci. 2018;4(2):110–128.
  • Jacobsen D, Haines JA. The relative efficacy of antidotes: the IPCS evaluation series. International Programme on Chemical Safety. Arch Toxicol Suppl. 1997;19:305–310.9079217
  • Farjadian F, Ahmadpour P, Samani S, Hosseini M. Controlled size synthesis and application of nanosphere MCM-41 as potent adsorber of drugs: a novel approach to new antidote agent for intoxication. Microporous Mesoporous Mater. 2015;213:30–39. doi:10.1016/j.micromeso.2015.04.002
  • Farjadian F, Ghasemi S, Heidari R, Mohammadi-Samani S. In vitro and in vivo assessment of EDTA-modified silica nano-spheres with supreme capacity of iron capture as a novel antidote agent. Nanomed. 2017;13(2):745–753. doi:10.1016/j.nano.2016.10.012
  • Kalantari S, Yousefpour M, Taherian Z. Synthesis of mesoporous silica/iron oxide nanocomposites and application of optimum sample as adsorbent in removal of heavy metals. Rare Metals. 2017;36(12):942–950. doi:10.1007/s12598-016-0709-4
  • Huang J, Ye M, Qu Y, et al. Pb (II) removal from aqueous media by EDTA-modified mesoporous silica SBA-15. J Colloid Interface Sci. 2012;385(1):137–146. doi:10.1016/j.jcis.2012.06.05422874637
  • Ranucci G, Di Dato F, Leone F, Vajro P, Spagnuolo M, Iorio R. Penicillamine-induced elastosis perforans serpiginosa in wilson disease: is useful switching to zinc? J Pediatr Gastroenterol Nutr. 2017;64(3):e72–e73. doi:10.1097/MPG.000000000000061325341025
  • Yu H, Xie -J-J, Chen Y-C, et al. Clinical features and outcome in patients with osseomuscular type of Wilson’s disease. BMC Neurol. 2017;17(1):34. doi:10.1186/s12883-017-0818-128212618
  • Favre E, Lion-François L, Canton M, et al. Cognitive abilities of children with neurological and liver forms of Wilson disease. J Pediatr Gastroenterol Nutr. 2017;64(3):436–439.27482767
  • Walshe J. Penicillamine neurotoxicity: an hypothesis. ISRN Neurol. 2011;2011 10.5402/2011/464572
  • Etienne M, Lebeau B, Walcarius A. Organically-modified mesoporous silica spheres with MCM-41 architecture. N J Chem. 2002;26(4):384–386. doi:10.1039/b110741k
  • Ho Y-S. Isotherms for the sorption of lead onto peat: comparison of linear and non-linear methods. Pol J Environ Stud. 2006;15:1.
  • Farjadian F, Schwark S, Ulbricht M. Novel functionalization of porous polypropylene microfiltration membranes: via grafted poly (Aminoethyl methacrylate) anchored schiff base toward membrane adsorbers for metal ions. Polym Chem. 2015;6(9):1584–1593. doi:10.1039/C4PY01521E.
  • Chen Z, Meng H, Xing G, et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett. 2006;163(2):109–120. doi:10.1016/j.toxlet.2005.10.00316289865
  • Heidari R, Mohammadi H, Ghanbarinejad V, et al. Proline supplementation mitigates the early stage of liver injury in bile duct ligated rats. J Basic Clin Physiol Pharmacol. 2019;30(1):91–101. doi:10.1515/jbcpp-2017-0221